Around 1 in 10 cases worldwide might be associated with drinking alcohol, estimate the researchers.
This study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple sclerosis (PMS).
Cerdelga is indicated for the long-term treatment of adult patients with Gaucher disease type 1 (GD1), who are CYP2D6 poor metabolisers (PMs), intermediate metabolisers (IMs) or extensive metabolisers (EMs).
This guideline covers assessing and managing heavy menstrual bleeding (menorrhagia).
The National Institute for Health and Care Excellence (NICE) has published guidelines recommending Esmya (ulipristal acetate), a blocker of progesterone,...